{"id":"62ebea1e-7696-5a38-b2ad-ab0a13038303","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-fenamates-do-not-block-it","predicate":"preserves_measured_pool","statement":"The production of 15-HETE by aspirin-modified cyclooxygenase-2 was sensitive to inhibition by most non-steroidal anti-inflammatory drugs including selective cyclooxygenase-2 inhibitors and the inhibition by indomethacin was time-dependent, but two potent structurally related drugs, diclofenac and meclofenamic acid, did not inhibit either the acetylated enzyme or the S516M mutant, so Ser516 plays an important role in the interaction with fenamate inhibitors.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"neutral","is_public":true,"mechanism_event_id":"d2d8eac0-3ed7-5904-8762-cef67a338569","mechanism_event_label":"Two common anti-inflammatories cannot touch the rerouted enzyme, because they needed the serine aspirin has taken.","subject":{"id":"2d3faead-6df2-5e17-ad25-6f7c20a2ae05","slug":"diclofenac","display_name":"Diclofenac","entity_type_key":"drug"},"object":{"id":"a8fa3506-620f-5c71-a0f1-226962e93b69","slug":"15r-hete","display_name":"15(R)-hydroxyeicosatetraenoic acid","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"d2d8eac0-3ed7-5904-8762-cef67a338569","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-fenamates-do-not-block-it-event","event_type":"observed_intervention","label":"Two common anti-inflammatories cannot touch the rerouted enzyme, because they needed the serine aspirin has taken.","description":"The production of 15-HETE by aspirin-modified cyclooxygenase-2 was sensitive to inhibition by most non-steroidal anti-inflammatory drugs including selective cyclooxygenase-2 inhibitors and the inhibition by indomethacin was time-dependent, but two potent structurally related drugs, diclofenac and meclofenamic acid, did not inhibit either the acetylated enzyme or the S516M mutant, so Ser516 plays an important role in the interaction with fenamate inhibitors.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"afdba139-45ee-58d9-9d9e-7b5001d982b5","slug":"meclofenamic-acid","display_name":"Meclofenamic acid","entity_type_key":"chemical_species"},"role":"co_inactive_drug","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"b4ad67ed-ff1f-5c41-a6a4-040205a3bdf3","slug":"indomethacin","display_name":"Indomethacin","entity_type_key":"small_molecule"},"role":"active_comparator","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"48cd6cab-de3d-53bd-a690-a1f9e5b78a7d","slug":"cox2-ser516","display_name":"Serine 516 of cyclooxygenase-2","entity_type_key":"protein_state"},"role":"required_residue","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"2d3faead-6df2-5e17-ad25-6f7c20a2ae05","slug":"diclofenac","display_name":"Diclofenac","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"a8fa3506-620f-5c71-a0f1-226962e93b69","slug":"15r-hete","display_name":"15(R)-hydroxyeicosatetraenoic acid","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/aspirin-research/9016346.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"2cc2efefceabbee7bb4f1052db8fc86ee218409fe56981cf92b707c7b0ef531b\", \"start_char\": 0, \"end_char\": 1899, \"text_sha256\": \"2cc2efefceabbee7bb4f1052db8fc86ee218409fe56981cf92b707c7b0ef531b\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Kinetic characterisation of aspirin-acetylated cyclooxygenase-2 and the S516M mutant against a panel of non-steroidal anti-inflammatory drugs","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Aspirin acetylation and the methionine mutant, tested with indomethacin, diclofenac, meclofenamic acid and selective inhibitors","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Quantifies how efficient the new activity is, which most descriptions of the switch do not. Purified and recombinant enzyme rather than intact cells.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.","comparator":null,"unit":null,"notes":"","entity":{"slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Enzyme","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Two common anti-inflammatories cannot touch the rerouted enzyme, because they needed the serine aspirin has taken.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[asa-p9016346] Altered sensitivity of aspirin-acetylated prostaglandin G/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs. (1997). https://pubmed.ncbi.nlm.nih.gov/9016346/ DOI: 10.1124/mol.51.1.52","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Cyclooxygenase-2","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"40df76fa-c009-5ee9-87d0-28157d9324f3","evidence_kind":"source_excerpt","locator":"Lines 273-284","start_line":273,"end_line":284,"excerpt":"### asa-fenamates-do-not-block-it\nThe production of 15-HETE by aspirin-modified cyclooxygenase-2 was sensitive to inhibition by most non-steroidal anti-inflammatory drugs including selective cyclooxygenase-2 inhibitors and the inhibition by indomethacin was time-dependent, but two potent structurally related drugs, diclofenac and meclofenamic acid, did not inhibit either the acetylated enzyme or the S516M mutant, so Ser516 plays an important role in the interaction with fenamate inhibitors.\nCondition category: normal\nnutrient_topic: Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.\nplain_language: Two common anti-inflammatories cannot touch the rerouted enzyme, because they needed the serine aspirin has taken.\norganism: Enzyme\ntissue_or_cell_type: Cyclooxygenase-2\nexperimental_model: Kinetic characterisation of aspirin-acetylated cyclooxygenase-2 and the S516M mutant against a panel of non-steroidal anti-inflammatory drugs\nlimitations: Quantifies how efficient the new activity is, which most descriptions of the switch do not. Purified and recombinant enzyme rather than intact cells.\nexposure: Aspirin acetylation and the methionine mutant, tested with indomethacin, diclofenac, meclofenamic acid and selective inhibitors\nevidence_span: {\"source_cache\": \"artifacts/aspirin-research/9016346.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"2cc2efefceabbee7bb4f1052db8fc86ee218409fe56981cf92b707c7b0ef531b\", \"start_char\": 0, \"end_char\": 1899, \"text_sha256\": \"2cc2efefceabbee7bb4f1052db8fc86ee218409fe56981cf92b707c7b0ef531b\"}\n[asa-p9016346] Altered sensitivity of aspirin-acetylated prostaglandin G/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs. (1997). https://pubmed.ncbi.nlm.nih.gov/9016346/ DOI: 10.1124/mol.51.1.52","model_system":"Kinetic characterisation of aspirin-acetylated cyclooxygenase-2 and the S516M mutant against a panel of non-steroidal anti-inflammatory drugs","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [asa-p9016346] Altered sensitivity of aspirin-acetylated prostaglandin G/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs. (1997). https://pubmed.ncbi.nlm.nih.gov/9016346/ DOI: 10.1124/mol.51.1.52","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"712cf519-cd27-5a8b-9e2f-961a98d7a27e","stable_key":"import-f8641d02-8413-5bd8-92e9-62ad49286e81","title":"Aspirin: the serine it acetylates, the enzyme that acetylation creates, the dose that separates platelet from vessel wall, and the metabolite that is a different drug (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"93dd4343051c131e40d4fc3c95a978cd65478c13dcdb3f2d42507c49b09cb647","revision_id":"694e8ee7-49ca-5e6c-b58b-8ba8f82c2ad8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}